Announcing our Frozen Facility (-25°C to -15°C) Investment in Singapore
July 9, 2024
As part of our long-term site management strategy and commitment to stability in service growth, we are delighted to announce that Almac have invested SG$ 3.2 million at our Asia Pacific headquarters in Singapore.
This investment in the APAC region will expand the scope of Almac’s services for Sponsors, including our global secondary clinical supply packaging and leading temperature-controlled clinical supply and logistics solutions, to include:
- A new frozen facility operating between -25°C to -15°C, offering four times the original floor space and approximately 480 additional storage locations for production and logistical activities.
- Implementation of a 1:1 refrigeration system design for 100% redundancy
- A dedicated secondary production room equipped with frozen conditions, further enhancing our global secondary supply packaging and temperature-controlled clinical supply and logistics services.
Clients with material in our current frozen stores will be contacted and advised of any movement of material into our new frozen facility governed by our standard processes and agreements.
Investing in the Future of Human Health
Paul O’Connor, Global Vice President, Quality comments “Almac’s mission to support sponsors in advancing human health has remained steadfast. The continued growth of the regenerative medicine market has galvanised our commitment to customers, and the patients they serve, and has been the driving force in our decision to expand our temperature-controlled offering. As demand continues to increase, as will our investment across Almac’s global network.”
For more information, please contact your Business Development or Key Account Manager, alternatively, you can email info@almacgroup.com.